Title : Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice.

Pub. Date : 2020

PMID : 33163410






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Patients in the EGFR/ALK-negative/unknown cohort treated with first-line pemetrexed with platinum (PP) (15.8 months, 14.0-17.6, p<0.001) had longer mOS than those received non-PP regimens (13.1 months, 11.6-14.6). Platinum Moloney sarcoma oncogene Mus musculus